| خلاصه مقاله | Aim:Misconduct is one of the important issues on research integrity. Cochrane systematic
reviews are known for their best level of evidences. Considering kidney and transplant group is
responsible for identifying all trial-related kidney disease, evaluation the relevance and quality of
trials, collection and analysis of trial data and preparing reports for inclusion them in systematic
reviews of the Cochrane Database and regarding kidney disease is the 9th leading cause of death
in the United State, hence this study aimed to assess quality of randomized controlled trials
included in Cochrane systematic reviews of kidney and transplant group.
Methods:This analytic cross-sectional study was conducted on 147 systematic reviews of kidney
and transplant group of Cochrane reviews and a total of 2475 RCTs had been appraised by
CONSORT checklist that included all kinds of biases (selection, performance, detection, attrition
and reporting. Descriptive statistics were used to analysis the data through SPSS 16 and also
partial correlation was done to report the outcomes.
Results:In a total of 2457 RCTs the most high risk bias had been seen in Random Sequence
Generation bias (55%) and Performance bias (35%) respectively. Whereas 20% of studies in
allocation bias, 41% incomplete outcome bias, 46% selection bias and 33% detection bias were
low risk.
According to the findings, during 2008-2009, high random sequence generation bias dramatically
has increased and after decreasing, gradual growth has been continuing over the time.
Furthermore, low detection bias has reduced surprisingly in 2011 then decreased during 20122013.
Conclusion:Regarding
to
high risks
of
performance
and random
sequence
generation
biases
in
understudied
RCTs, it’s
obvious
they
have
critical
structure
deficiencies.
Therefore,
it’s
recommended
observing
integrity
principles
for preventing
research
misconduct. |